These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8587751)

  • 1. 'Knowingly and willingly in the support and comfort of a patient'.
    Harding LK; Thomson WH
    Nucl Med Commun; 1995 Nov; 16(11):877-8. PubMed ID: 8587751
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation protection issues associated with nuclear medicine out-patients.
    Thomson WH; Harding LK
    Nucl Med Commun; 1995 Nov; 16(11):879-92. PubMed ID: 8587752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictions following iodine-131 treatment--a time for change or more data required?
    Mountford PJ; O'Doherty MJ
    Eur J Nucl Med; 1994 Sep; 21(9):903-5. PubMed ID: 7995282
    [No Abstract]   [Full Text] [Related]  

  • 4. Doses in family members after 131I treatment.
    Mathieu I; Caussin J; Smeesters P; Wambersie A; Beckers C
    Lancet; 1997 Oct; 350(9084):1074-5. PubMed ID: 10213553
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of radiation doses received by the public from 131I treatment of thyrotoxic outpatients.
    Wasserman HJ; Klopper JF
    Nucl Med Commun; 1993 Sep; 14(9):756-60. PubMed ID: 8233240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation protection issues associated with nuclear medicine out-patients.
    Hilditch TE; Elliott AT
    Nucl Med Commun; 1996 May; 17(5):441-2, 445-6. PubMed ID: 8736523
    [No Abstract]   [Full Text] [Related]  

  • 7. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism.
    Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release criteria from hospitals of 131I thyrotoxicosis therapy patients in developing countries--case study.
    Muhammad W; Faaruq S; Matiullah ; Hussain A; Khan AA
    Radiat Prot Dosimetry; 2006; 121(2):136-9. PubMed ID: 16464838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131.
    Cappelen T; Unhjem JF; Amundsen AL; Kravdal G; Følling I
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):81-6. PubMed ID: 16151768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive improvement in the approach to the treated patient as a radioactive source.
    Lubin E
    J Nucl Med; 2002 Mar; 43(3):364-5. PubMed ID: 11884496
    [No Abstract]   [Full Text] [Related]  

  • 11. External and internal dose to individuals after (131)I outpatient therapy.
    Wooten WW
    J Nucl Med; 2002 Apr; 43(4):575; author reply 575. PubMed ID: 11937604
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation protection issues.
    O'Doherty MJ; Barrington SF; Kettle AG; Mountford PJ; Coakley AJ
    Nucl Med Commun; 1996 May; 17(5):443-6. PubMed ID: 8736524
    [No Abstract]   [Full Text] [Related]  

  • 13. Criteria for safe working with iodine-125.
    Linsley GS
    Radiography; 1977 Apr; 43(508):91-3. PubMed ID: 860017
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years?
    Shapiro B
    J Nucl Med; 1993 Oct; 34(10):1638-41. PubMed ID: 8410274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Who will receive iodine-131 therapy in thyrotoxicosis?].
    Nyström E; Berg G
    Lakartidningen; 1992 Dec; 89(51-52):4483. PubMed ID: 1469993
    [No Abstract]   [Full Text] [Related]  

  • 16. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
    Marcus CS; Siegel JA
    J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
    [No Abstract]   [Full Text] [Related]  

  • 17. Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium).
    Monsieurs M; Thierens H; Dierckx RA; Casier K; De Baere E; De Ridder L; De Saedeleer C; De Winter H; Lippens M; van Imschoot S; Wulfrank D; Simons M
    Eur J Nucl Med; 1998 Oct; 25(10):1368-76. PubMed ID: 9818275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose constraints and guidance for exposure of individuals knowingly and willingly helping in the support and comfort of individuals undergoing medical exposure.
    Jansen JT; Zoetelief J;
    Radiat Prot Dosimetry; 2006; 118(3):315-24. PubMed ID: 16439517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroidal absorbed dose from a standard five-millicurie iodine-131 (185 MBq) dose for thyrotoxicosis: cure can occur with less than the conventional 7000 rads.
    Rajashekharrao B; Nair N
    J Nucl Med; 1991 Feb; 32(2):364-5. PubMed ID: 1992045
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioiodine therapy of thyrotoxicosis.
    Gross MD; Shapiro B; Sisson JC
    Rays; 1999; 24(2):334-47. PubMed ID: 10509135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.